INVO Fertility, Inc. Adjustments to Additional Paid in Capital, Fair Value
INVO Fertility, Inc. (IVF) had Adjustments to Additional Paid in Capital, Fair Value of $85.12 thousand as of 2025-07-23, per its 10-K filed 2026-06-02.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket · last filed 2026-06-02
- 2025-07-23: Adjustments to Additional Paid in Capital, Fair Value $85.12K.
| Period end | Adjustments to Additional Paid in Capital, Fair Value |
|---|---|
| 2025-07-23 | $85.12K 10-K · filed 2026-06-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |